Transdermal patches (TDDS formulation)

TOYOCHEM offers products for medical drugs, pharmaceutical additives, medical devices, and diagnostic reagents.
We began manufacturing ethical pharmaceuticals in 1994, and have developed a CDMO business specializing in transdermal patches, conducting contract research and contract manufacturing with many pharmaceutical companies.
In other product groups, we are promoting the unique development of pressure sensitive adhesives, resins, adhesive tapes, etc. for the medical and healthcare fields using our core technologies of polymer synthesis technology and coatings technology. We are also developing new technologies by deepening our collaboration with academia.

What is transdermal patches? (Transdermal Drug Delivery System)

What is transdermal absorption technology?

• Business summary
• Examples of products we handle
• Business history

Business summary

TOYOCHEM 's transdermal patches (TDDS formulations) are pharmaceuticals that are applied to the body to continuously administer active ingredients through the skin.
When it comes to transdermal patches, anti-inflammatory and analgesic transdermal patches are generally known, but our products are called ``systemic-acting'' and are used to treat diseases where the cause of the disease is internal to the body (angina heart). This drug is used to treat diseases such as symptoms.
Advantages of transdermal patches include (1) the ability to maintain effective blood concentrations and reduce side effects, and (2) ease of handling.
We also operate a CDMO business specializing in transdermal patches.

CDMO (contract research / manufacturing)

Examples of products we handle

TOYOCHEM manufactures the following transdermal patches on contract:

We are a CDMO specializing not in topical transdermal medicines such as pain relievers, but in an ethical systematic one.

Business history